[07:22] A Yeah, no, it was not even on purpose
Funding This work was funded by the Research Council of Norway (228542/O30, 245598/O30, 281920), AlgiPharma AS, European Social Fund (KESS2 Programme 517052) and the Sr Cymru II programme which is part-funded by Cardiff University and the European Regional Development Fund through the Welsh Government (80762-CU176)
The side effects most frequently reported in the clinical literature and in real-world use are typically mild and dose-related: Injection site reaction: Brief redness, mild soreness, or small bruising at the injection site
The current article focusses on understanding the structural diversity of skin cancers, treatments available till date including phytocompounds, chemotherapy, radiotherapy, photothermal therapy, surgery, combination therapy, molecular targets associated with cancer growth and metastasis, and special emphasis on nanotechnology-based approaches for downregulating the deleterious disease